Compare DRTS & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | ADAM |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | Israel | United States |
| Employees | 121 | 221 |
| Industry | Medical/Dental Instruments | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.0M | 655.0M |
| IPO Year | N/A | N/A |
| Metric | DRTS | ADAM |
|---|---|---|
| Price | $7.27 | $7.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $8.67 | ★ $9.17 |
| AVG Volume (30 Days) | 205.5K | ★ 630.4K |
| Earning Date | 05-18-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $965.57 | $4.52 |
| P/E Ratio | ★ N/A | $41.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.50 | $6.45 |
| 52 Week High | $8.60 | $8.76 |
| Indicator | DRTS | ADAM |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 47.25 |
| Support Level | $6.37 | $7.06 |
| Resistance Level | $7.75 | $7.75 |
| Average True Range (ATR) | 0.43 | 0.19 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 69.60 | 68.87 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.